ABIO · Categories · 13D

ABIO - SEC Schedule 13D filings

ARCA biopharma Inc. (ABIO) sec schedule 13d filings - real-time wire coverage filtered to 13D only.

Recent 13D for ABIO

• 590d
  Amendment: SEC Form SC 13D/A filed by ARCA biopharma Inc.

  SC 13D/A - Oruka Therapeutics, Inc. (0000907654) (Subject)
• 597d
  SEC Form SC 13D filed by ARCA biopharma Inc.

  SC 13D - Oruka Therapeutics, Inc. (0000907654) (Subject)
• 751d
  SEC Form SC 13D filed by ARCA biopharma Inc.

  SC 13D - ARCA biopharma, Inc. (0000907654) (Subject)
• 1388d
  SEC Form SC 13D/A filed by ARCA biopharma Inc. (Amendment)

  SC 13D/A - ARCA biopharma, Inc. (0000907654) (Subject)
• 1405d
  SEC Form SC 13D/A filed by ARCA biopharma Inc. (Amendment)

  SC 13D/A - ARCA biopharma, Inc. (0000907654) (Subject)
• 1430d
  SEC Form SC 13D/A filed by ARCA biopharma Inc. (Amendment)

  SC 13D/A - ARCA biopharma, Inc. (0000907654) (Subject)
• 1446d
  SEC Form SC 13D/A filed by ARCA biopharma Inc. (Amendment)

  SC 13D/A - ARCA biopharma, Inc. (0000907654) (Subject)
• 1473d
  SEC Form SC 13D/A filed by ARCA biopharma Inc. (Amendment)

  SC 13D/A - ARCA biopharma, Inc. (0000907654) (Subject)
• 1483d
  SEC Form SC 13D/A filed by ARCA biopharma Inc. (Amendment)

  SC 13D/A - ARCA biopharma, Inc. (0000907654) (Subject)
• 1490d
  SEC Form SC 13D filed by ARCA biopharma Inc.

  SC 13D - ARCA biopharma, Inc. (0000907654) (Subject)

Other ABIO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends